Back to Results

Angie Mae Rodday, PhD, MS

Training + Education Harvard TH Chan School of Public Health; Tufts University Graduate School of Biomedical Science
Gender Female

2018 – 2020, NIH Loan Repayment Program Award
2018, Third Place, International Society of Quality of Life (ISOQOL) Outstanding Article of the Year
2015, Tufts Breast Cancer Training Program to Reduce Asian Health Disparities, Susan G. Komen Graduate Training in Disparities Research Program
2014, Norman G and Susan I Krinsky Award for Excellence in Basic Science Teaching Award, Tufts University Graduate School of Biomedical Science
2013-2015, Health Outcomes Award, PhRMA Foundation Pre-Doctoral Fellowship

Rodday AM, Parsons SK, Upshaw JN, Friedberg JW, Gallamini A, Hawkes E, Hodgson D, Johnson P, Link BK, Mou E, Savage KJ, Zinzani PL, Maurer M, Evens AM. The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. J Clin Oncol. 2022 Dec 10;:JCO2202473. doi: 10.1200/JCO.22.02473.

Linendoll N, Murphy-Banks R, Sae-Hau M, Rodday AM, DiFilippo C, Jain A, Reinhart C, Rapkin B, Weiss E, Parsons SK. Evaluating the role of financial navigation in alleviating financial distress among young adults with a history of blood cancer: A hybrid type 2 randomized effectiveness-implementation design. Contemp Clin Trials. 2023 Jan;124:107019. doi: 10.1016/j.cct.2022.107019. 

Penney JA, Rodday AM, Sebastiani P, Snydman DR, Doron S. Effecting the Culture: Impact of Changing Urinalysis with Reflex to Culture Criteria on Culture Rates and Outcomes. Infection Control and Hospital Epidemiology. 2022. Aug 4:1-6. doi: 10.1017/ice.2022.178.

Waheed A, Rodday AM, Kumar AJ, Miller KB, Parsons SK. Hematopoietic Stem Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population-Level Analysis of Statewide Claims Data. JCO Clinical Cancer Informatics. 2022 May;6:e2100135. doi: 10.1200/CCI.21.00135.

Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK. Association between Treatment Intensity and Survival in Older Patients with Hodgkin Lymphoma: a SEER-Medicare Population-based Study. JAMA Netw Open. 2021 Oct 1;4(10):e2128373. doi: 10.1001/jamanetworkopen.2021.28373. 

Rodday AM, Esham KS, Savidge N, Parsons SK. Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso-occlusive crisis: a data-driven approach. EJHaem. 2020 Nov;1(2):426-437.

Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK. First-line treatment in older patients with Hodgkin lymphoma: a SEER population-based study. Br J Haematol. 2020 Jul;190(2):222-235. doi: 10.1111/bjh.16525.

Rodday AM, Graham RJ, Weidner RA, Rothrock NE, Dewalt DA, Parsons SK. Leveraging pediatric PROMIS item banks to assess physical functioning in children at risk for severe functional loss. J Patient Rep Outcomes. 2017;1(1):10. doi: 10.1186/s41687-017-0011-8. 

Rodday AM, Terrin N, Leslie LK, Graham RJ, Parsons SK. Understanding the Relationship Between Child Health-Related Quality of Life and Parent Emotional Functioning in Pediatric Hematopoietic Stem Cell Transplant. J Pediatr Psychol. 2017 Aug 1;42(7):804-814. doi: 10.1093/jpepsy/jsx047. 

Rodday AM, Parsons SK, Snyder F, Simon MA, Llanos AAM, Warren-Mears V, Dudley D, Lee J, Patierno SR, Markossian TW, Sanders M, Whitley E, Freund KM. Impact of Patient Navigation in Eliminating Economic Disparities in Cancer Care. Cancer. 2015; 121(22):4025-4034. doi: 10.1002/cncr.29612.

Angie Mae Rodday, PhD, MS, is an Assistant Professor of Medicine and an Investigator in the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center. Dr. Rodday is also a Biostatistician within the Tufts CTSI Biostatistics, Epidemiology, and Research Design (BERD) Center and an Associate Director of the Tufts Clinical and Translational Science Graduate Program. She earned her PhD in Clinical and Translational Science from Tufts University Graduate School of Biomedical Sciences, her MS in biostatistics from the Harvard TH Chan School of Public Health, and her BA in psychology from Tufts University.

Dr. Rodday's research interests include the design and analysis of clinical outcomes and health services research, with a focus on hematology/oncology. She has experience designing studies using real-world data, analyzing patient-reported outcomes, developing surveys to assess physician attitudes and preferences, and evaluating care delivery. Most recently, she is working on a research project that models acute and long-term outcomes of patients with Hodgkin lymphoma using clinical trial and real-world registry data.

She has worked on studies that evaluated the health-related quality of life of patients with different medical conditions, analyzed large existing databases to understand disease prevalence and practice patterns, and conducted comparative effectiveness analyses of different clinical guidelines.

Academy Health
American Society of Hematology
American Statistical Association
Association for Clinical and Translational Science

The Center for Health Solutions
800 Washington St., Box 345
Boston, MA 02111

Phone: 617-636-7193